VENDOR COMPARISON

Astro Peptides vs Peptide Technologies

Independent side-by-side comparison across the 0 peptides both vendors sell. Composite scores, lab quality, and verified pricing.

Astro Peptides

Research
B
Score
6.7
Peptides
8
Tests
43

8 peptides with 43 lab tests. Lowest verified $/mg on Semaglutide ($7.90/mg vs $9.40 market median).

Astro Peptides full review →

Peptide Technologies

Research
B
Score
6.3
Peptides
8
Tests
31

5 BPC-157 tests with score variance 5.0–10.0. GHK-Cu and Ipamorelin coverage solid.

Peptide Technologies full review →

Side-by-side breakdown

PEPTIDE ASTRO PEPTIDES PEPTIDE TECHNOLOGIES WINNER
Semaglutide
8.7 B+ (11 tests)
(not sold)
Astro Peptides only
Ipamorelin
8.6 B+ (7 tests)
(not sold)
Astro Peptides only
GHK-Cu
(not sold)
7.4 B (6 tests)
Peptide Technologies only
BPC-157
(not sold)
6.5 B (5 tests)
Peptide Technologies only

Which to choose

Across the 0 peptides both vendors sell, Astro Peptides scores higher on 0, Peptide Technologies scores higher on 0, and 0 are within 0.3 points (effectively tied). Peptide Technologies additionally sells GHK-Cu, BPC-157; Astro Peptides does not. Astro Peptides additionally sells Semaglutide, Ipamorelin; Peptide Technologies does not.

Composite scores reflect lab quality, sentiment, COA transparency, reliability, and price. How we score.

Full profiles: Astro Peptides review · Peptide Technologies review